Levi & Korsinsky Investigates Alector, Inc. (ALEC) Over Possible Securities Fraud
NEW YORK, NY / ACCESS Newswire / November 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with […]